ApoE E4 is a Susceptibility Factor in Amnestic but Not Aphasic Dementias

Alzheimer Disease and Associated Disorders

Volumn 25, Issue 2, 2011, Pages 159-163

  Rogalski, Emily Joy ^a   Rademaker, Alfred ^b   Harrison, Theresa M ^a   Helenowski, Irene ^b   Johnson, Nancy ^a,b   Bigio, Eileen ^a,b   Mishra, Manjari ^a   Weintraub, Sandra ^a,b   Mesulam, Marek Marsel ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Preventive Medicine ^*  (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer disease; frontotemporal dementia; genetics; genotype; pathology; Primary progressive aphasia; risk factor

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PROBABLE ALZHEIMER DISEASE;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APHASIA, PRIMARY PROGRESSIVE; APOLIPOPROTEIN E4; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79958274677     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e318201f249     Document Type: Article

References (26)

1. Mesulam M, Weintraub S. Primary progressive aphasia and kindred disorders. Handb Clin Neurol. 2008;89:573-587.
2. Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006;20:210-216. (Pubitemid 44900933)
3. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
4. Ariza M, Pueyo R, Matarin Mdel M, et al. Influence of ApoE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. J Neurol Neurosurg Psychiatry. 2006;77:1191-1193. (Pubitemid 44453257)
5. Louko AM, Vilkki J, Niskakangas T. ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study. Acta Neurol Scand. 2006;114:315-319. (Pubitemid 44526644)
6. Tian J, Shi J, Bailey K, et al. Association between apolipo-protein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004;75:696-699. (Pubitemid 38526678)
7. Li YJ, Pericak-Vance MA, Haines JL, et al. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics. 2004;5:209-213. (Pubitemid 40174640)
8. Li YJ, Hauser MA, Scott WK, et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology. 2004;62:2005-2009. (Pubitemid 38738212)
9. Tsuang DW, Dalan AM, Eugenio CJ, et al. Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families. Arch Neurol. 2002;59:1622-1630.
10. Mesulam MM, Johnson N, Grujic Z, et al. Apolipoprotein E geno-types in primary progressive aphasia. Neurology. 1997;49:51-55. (Pubitemid 27328681)
11. Masullo C, Daniele A, Fazio VM, et al. The Apolipoprotein E genotype in patients affected by syndromes with focal cortical atrophy. Neurosci Lett. 2001;303:87-90. (Pubitemid 32320011)
12. Pickering-Brown SM, Siddons M, Mann DM, et al. Apolipo-protein E allelic frequencies in patients with lobar atrophy. Neurosci Lett. 1995;188:205-207.
13. Acciarri A, Masullo C, Bizzarro A, et al. Apoe epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasia. Ann Neurol. 2006;59:436-437. (Pubitemid 43202511)
14. Agosta F, Vossel KA, Miller BL, et al. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc Natl Acad Sci USA. 2009;106:2018-2022.
15. Daniele A, Matera MG, Seripa D, et al. ApoE epsilon 2/ep-silon 4 genotype a risk factor for primary progressive aphasia in women. Arch Neurol. 2009;66:910-912.
16. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545-548. (Pubitemid 20107994)
17. McKhann GM, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944. (Pubitemid 14076461)
18. Mesulam MM. Primary progressive aphasia. Ann Neurol. 2001;49:425-432. (Pubitemid 32281326)
19. Mesulam MM. Primary progressive aphasia:a language-based dementia. N Engl J Med. 2003;349:1535-1542.
20. Mesulam M, Wieneke C, Rogalski E, et al. Quantitative template for subtyping primary progressive aphasia. Arch Neurol. 2009;66:1545-1551.
21. Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progres-sive aphasia. Ann Neurol. 2004;55:335-346. (Pubitemid 38269585)
22. Stevens M, van Duijn CM, de Knijff P, et al. Apolipoprotein E gene and sporadic frontal lobe dementia. Neurology. 1997; 48:1526-1529.
23. Rabinovici GD, Jagust WJ, Furst AJ, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol. 2008;64:388-401.
24. Mesulam M, Wicklund A, Johnson N, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol. 2008;63:709-719. (Pubitemid 351945530)
25. Knibb JA, Xuereb J, Patterson K, et al. Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006;59:156-165. (Pubitemid 43042882)
26. Migliaccio R, Agosta F, Rascovsky K, et al. Clinical syndromes associated with posterior atrophy: early age at onsetAD spectrum. Neurology. 2009;73:1571-1578.